Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17825837 | 0.79 | CYP19A1 (0.59) | CYP19A1 | |
| SCHEMBL27494651 | 0.74 | CYP19A1 (0.57) | KMT2AMEN1CYP19A1CYP1A2CYP2D6 | |
| SCHEMBL4581851 | 0.74 | NOTUM (0.42) | SMN1; SMN2KMT2AKDM4EMEN1NOTUM | |
| SCHEMBL4312003 | 0.73 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AKDM4EMEN1NOTUM | |
| SCHEMBL11499232 | 0.72 | TSHR (0.41) | CYP19A1CYP2D6EPHX1LMNA | |
| SCHEMBL29788839 | 0.70 | CYP2D6 (0.44) | KMT2AKDM4EMEN1NOTUMNPSR1 | |
| SCHEMBL29788853 | 0.70 | CYP2D6 (0.44) | KMT2AKDM4EMEN1NOTUMNPSR1 | |
| SCHEMBL29788864 | 0.70 | CYP2D6 (0.44) | KMT2AKDM4EMEN1NOTUMNPSR1 | |
| SCHEMBL4371708 | 0.69 | TBXAS1 (0.43) | SMN1; SMN2KMT2AKDM4EMEN1NPSR1 | |
| SCHEMBL29185684 | 0.69 | ELANE (0.38) | SMN1; SMN2KMT2AKDM4EMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9430113-B2 | Electrically-conductive article with improved bus region | EASTMAN KODAK COMPANY (US) | 2016-08-30 | — | — | US | disclosed |
| US-9405423-B2 | Article with electrically-conductive silver connector wire pattern | EASTMAN KODAK COMPANY (US) | 2016-08-02 | — | — | US | disclosed |
| US-9405196-B2 | Method for preparing electrically-conductive silver images | EASTMAN KODAK COMPANY (US) | 2016-08-02 | — | — | US | disclosed |
| US-9304395-B2 | Conductive element precursor and conductive pattern formation | EASTMAN KODAK COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-20160062238-A1 | CONDUCTIVE ELEMENT PRECURSOR AND CONDUCTIVE PATTERN FORMATION | BANK OF AMERICA, N.A. | 2016-03-03 | — | — | US | disclosed |
| US-9261787-B1 | Conductive element precursor and conductive pattern formation | EASTMAN KODAK COMPANY (US) | 2016-02-16 | — | — | US | disclosed |
| US-9247640-B2 | Silver halide conductive element precursor and devices | EASTMAN KODAK COMPANY (US) | 2016-01-26 | — | — | US | disclosed |
| US-9235130-B2 | Method for preparing transparent conductive silver patterns | EASTMAN KODAK COMPANY (US) | 2016-01-12 | — | — | US | disclosed |
| US-20150338739-A1 | METHOD FOR PREPARING TRANSPARENT CONDUCTIVE SILVER PATTERNS | BANK OF AMERICA, N.A., AS AGENT | 2015-11-26 | — | — | US | disclosed |
| US-20150338738-A1 | METHOD FOR PREPARING ELECTRICALLY-CONDUCTIVE SILVER IMAGES | KODAK REALTY INC. | 2015-11-26 | — | — | US | disclosed |
| US-20150338969-A1 | ARTICLE WITH ELECTRICALLY-CONDUCTIVE SILVER CONNECTOR WIRE PATTERN | BANK OF AMERICA, N.A., AS AGENT | 2015-11-26 | — | — | US | disclosed |
| US-20150338970-A1 | ELECTRICALLY-CONDUCTIVE ARTICLE WITH IMPROVED BUS REGION | BANK OF AMERICA, N.A., AS AGENT | 2015-11-26 | — | — | US | disclosed |
| US-20150316848-A1 | CONDUCTIVE ELEMENT PRECURSOR AND CONDUCTIVE PATTERN FORMATION | BANK OF AMERICA, N.A. | 2015-11-05 | — | — | US | disclosed |
| US-20150216043-A1 | SILVER HALIDE CONDUCTIVE ELEMENT PRECURSOR AND DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2015-07-30 | — | — | US | disclosed |
| US-8362017-B2 | N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening | EXELIXIS, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| US-20080096892-A1 | C-Kit Modulators And Methods Of Use | EXELIXIS, INC. (US) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096892-A1 | C-Kit Modulators And Methods Of Use | KIT, PRKCH, PRKCB | SMN1; SMN2 3206/4885KMT2A 1897/4885KDM4E 1020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.